Link to our Twitter Profile – https://x.com/intent/user?screen_name=NiftyBN
Link to our Telegram Channel – https://t.me/niftybn
Link to our Instagram Handle – https://www.instagram.com/niftybn_/
Link to our Facebook Page – https://fb.com/niftybn
🎯 Sai Parenterals Secures ₹1,300 Crore International Supply Agreement
📅 July 1, 2026
Sai Parenterals’ subsidiary, Noumed Pharmaceuticals Pty Limited, has secured a major international supply agreement with one of Australia’s leading pharmacy networks. The long term contract significantly strengthens the company’s global presence in the over the counter medicines segment.
💊 Key Highlights
🔹 Major International Contract
• Noumed Pharmaceuticals Pty Limited, a subsidiary of Sai Parenterals, has secured an exclusive supply agreement.
• The agreement is with one of Australia’s leading pharmacy networks.
• The contract covers the exclusive supply of OTC medicines.
💰 Contract Details
• Contract value stands at approximately ₹1,300 crore.
• Equivalent to 202 million Australian Dollars.
• Base contract duration is 7.5 years.
🌍 Additional Terms
• The agreement includes an option to extend the contract by an additional 3 years through mutual consent.
• The company confirmed that this is an international contract.
• The transaction does not fall under related party transactions.
📈 Strategic Impact
• The order significantly strengthens Sai Parenterals’ global footprint.
• It enhances the company’s presence in the OTC medicines market through a long term international partnership.
#SaiParenterals #NoumedPharmaceuticals #Pharma #OTCMedicines #Australia #InternationalBusiness #Healthcare #Pharmaceuticals #SupplyAgreement #CorporateUpdates #StockMarketIndia #IndianStocks #BusinessNews #NSE #BSE #HealthcareSector #GlobalExpansion #Investing #Finance #CorporateNews
source
